Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
26%
OVERLAP
BY WEIGHT
8
# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
30%
ALSO IN CANC
CANC
56
HOLDINGS
14%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 17.2% | 4.5% | 4.5% |
 |
ASTRAZENECA PLC | 5.3% | 4.4% | 4.4% |
|
BRISTOL-MYERS SQUIBB CO | 5.0% | 4.3% | 4.3% |
|
MERCK & CO. INC. | 4.0% | 3.9% | 3.9% |
|
JOHNSON & JOHNSON | 5.6% | 2.5% | 2.5% |
MEDX Overweight Relative to CANC
|
ELI LILLY & CO | 12.7% |
 |
NOVARTIS AG-ADR | 7.3% |
|
ABBVIE INC | 5.9% |
|
IONIS PHARMACEUTICALS, INC. | 5.2% |
|
ALNYLAM PHARMACEUTICALS INC | 3.9% |
 |
ALKERMES PLC | 3.9% |
|
PFIZER INC | 3.4% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 3.3% |
|
JOHNSON & JOHNSON | 3.0% |
|
BIOGEN IDEC INC | 3.0% |
MEDX Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -6.2% |
|
NOVARTIS AG | -4.6% |
|
BRIDGEBIO PHARMA, INC. | -4.5% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.1% |
 |
GENMAB A/S SPONSORED ADR | -3.4% |
|
NUVALENT, INC. CLASS A | -3.3% |
|
COGENT BIOSCIENCES INC | -3.2% |
|
IMMUNOME, INC. | -2.9% |
|
CELCUITY INC. | -2.4% |
|
ARCELLX, INC. | -2.4% |